表紙
市場調查報告書

癌症診察的全球市場的未來展望 (2027年)

Global Cancer Screening Market Outlook 2027

出版商 Research Nester 商品編碼 940302
出版日期 內容資訊 英文 554 Pages
商品交期: 最快1-2個工作天內
價格
癌症診察的全球市場的未來展望 (2027年) Global Cancer Screening Market Outlook 2027
出版日期: 2020年05月01日內容資訊: 英文 554 Pages
簡介

癌症篩查的市場規模隨著癌症病例和患者數量的增加而不斷擴大,預計2020-2027年的複合年增長率約為9.67%。

本報告提供全球癌症診察市場未來趨勢相關分析,彙整市場基本結構和背景情況 (管理體制,主要的推動及阻礙市場要素,風險要素等),近幾年的技術進步的成果,市場規模趨勢預測 (今後9年份),檢驗手法·各癌症類型·各終端用戶及地區別詳細趨勢,目前市場競爭狀態,主要企業的簡介,產業相關人員的建議等資訊,為您概述為以下內容。

目錄

第1章 簡介

第2章 前提條件,縮寫

第3章 分析方法

第4章 摘要整理:全球癌症診察市場

第5章 法規情形

第6章 流行病學的分析

第7章 市場動態

  • 成長要素
  • 阻礙因素
  • 主要趨勢
  • 市場機會

第8章 主要製造商

第9章 近幾年的技術進步

第10章 癌症診察市場:風險分析

  • 需求風險分析
  • 供給風險分析

第11章 全球癌症診察市場未來展望

  • 市場規模與其預測 (2019∼2027年)
    • 市場規模 (2019∼2027年)
  • 全球癌症診察市場:各領域分析 (2019∼2027年)
    • 各檢驗方法
      • 遺傳基因檢驗 (以金額為準,2019∼2027年)
      • 設備為基礎的檢驗 (以金額為準,2019∼2027年)
      • 影像診斷 (以金額為準,2019∼2027年)
      • 內視鏡檢驗 (以金額為準,2019∼2027年)
      • 切片檢查 (以金額為準,2019∼2027年)
      • 平台型檢驗 (以金額為準,2019∼2027年)
    • 各癌症類型 (以金額為準,2019∼2027年)
      • 肺癌症,乳癌,結腸直腸癌症,前列腺癌症,血液癌症,肝癌症,胰臟癌症,皮膚癌症,子宮頸癌症等
    • 各終端用戶 (以金額為準,2019∼2027年)
      • 醫院,癌症診所,診斷中心等
  • 全球癌症診察市場:各地區分析
    • 北美 (以金額為準,2019∼2027年)
    • 歐洲 (以金額為準,2019∼2027年)
    • 亞太地區 (以金額為準,2019∼2027年)
    • 南美 (以金額為準,2019∼2027年)
    • 中東·非洲 (以金額為準,2019∼2027年)

第12章 競爭結構

  • 分析概要
  • 主要產品/服務的評估
  • 成長策略分析
  • 主要企業合作與合資企業
  • 主要的企業合併·收購 (M&A)
  • 最近的趨勢和動靜
  • 主要的客戶與合作夥伴
  • 主要財務指標相關綜合分析
  • 全球癌症診察市場:企業簡介
    • Roche
    • Abbott
    • Fujifilm
    • Siemens Healthineers
    • GE Healthcare
    • Thermo Fisher Scientific
    • Olympus
    • Agilent
    • 其他的企業

第13章 策略建議

目錄

COVID-19 update included

The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

According to the World Health Organization, the global cancer burden is estimated to have risen to 18.1 million new cases and 9.6 million deaths in 2018.Cancer screening tests are diagnostic procedures that are done in order to identify cancer in the body and therefore reduce the number of people who develop cancer or reach the later stages of cancer where it becomes untreatable. These tests can help to detect cancer at its early stages, where it may be easier to treat. The market for cancer screening is anticipated to grow at a significant CAGR of around 9.67% over the forecast period, i.e., 2020-2027.

The market is segmented by diagnostic methods, by cancer, by end user and by region. Based on the diagnostic methods, the market for cancer screening is segmented into genetic tests, instrument based tests and platform based tests. Out of these, the segment for instrument based tests is is anticipated to attain a market size of around USD 177,978 million by the year 2027 and is projected to grow with a significant CAGR over the forecast period. This segment is further divided into imaging tests, endoscopy procedures and biopsy, out of which, the segment for imaging tests is predicted to hold the leading share in the market on account of rising demand for minimally invasive procedures globally.

On the basis of region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in North America is anticipated to hold the leading share over the forecast period. The growth in the region can be attributed to the increase in investments towards healthcare from government and private entities in order to maintain the highest quality of care offered in healthcare facilities. Further, the market in Asia Pacific region is anticipated to grow with the highest CAGR of 11.12% over the forecast period on account of demand for new and improved technology and treatment methods from China. With the rising availability of advanced healthcare in Asia Pacific along with growing number of manufacturers investing in countries such as China, Japan, & India, the demand for cancer screening products in this region is estimated to witness a rapid growth in the coming years.

Some of the key industry leaders in the global cancer screening market are: Siemens Healthineers AG, GE Healthcare, Abbott, F. Hoffmann-La Roche Ltd., Olympus Corporation, FUJIFILM Corporation, Agilent Technologies, Inc. and Thermo Fisher Scientific.

TABLE OF CONTENTS

1. Introduction

  • 1.1. Market Definition
  • 1.2. Market Segmentation
  • 1.3. Product Overview

2. Assumptions And Acronyms

3. Research Methodology

4. Executive Summary - Global Cancer Screening Market

5. Regulatory Landscape

6. Epidemiology Analysis

7. Market Dynamics

  • 7.1. Growth Drivers
  • 7.2. Restraints
  • 7.3. Key Trends
  • 7.4. Opportunities

8. Key Manufacturers

9. Recent Technological Advancements

10. Cancer Screening Market - Risk Analysis

  • 10.1. Demand Risk Analysis
  • 10.2. Supply Risk Analysis

11. Global Cancer Screening Market Outlook

  • 11.1. Market Size And Forecast, 2019-2027
    • 11.1.1. By Value (Usd Million)
  • 11.2. Global Cancer Screening Market Segmentation, 2019-2027
  • By Diagnostic Method

V Genetic Tests: Brca Tests, Her2 Tests, Ca-125 Test Kras Mutation Tests, Alpha-Fetoprotein (Afp) Test, Ca-19 Radioimmunoassay Tests, Immunoglobulins Test, Chromogranin A (Cga) Tests, Others, 2019-2027f (Usd Million)

V Instrument Based Tests: Imaging Tests, Endoscopy Procedures & Biopsy, 2019-2027f (Usd Million)

Ø Imaging Tests: X-Rays, Computed Tomography (Ct), Magnetic Resonance Imaging (Mri), Positron Emission Tomography, Ultrasound & Mammography, 2019-2027f (Usd Million)

Ø Endoscopy Procedures: Bronchoscopy, Colonoscopy, Cystoscopy, Laparoscopy, Thoracoscopy & Others, 2019-2027f (Usd Million)

Ø Biopsy: Needle Biopsy, Bone Marrow Biopsy, Punch Biopsy, Skin Biopsy, Shave Biopsy & Others, 2019-2027f (Usd Million)

V Platform Based Tests: Immunohistochemistry, Next-Generation Sequencing, Pcr, Microarrays, Flow Cytometry, In-Situ Hybridization & Others, Chromogranin A (Cga) Tests & Others, 2019-2027f (Usd Million)

  • By Type Of Cancer

V Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Blood Cancer, Liver Cancer, Pancreatic Cancer, Skin Cancer, Cervical Cancer & Others, 2019-2027f (Usd Million)

  • By End User

V Hospitals, Oncology Clinics, Diagnostic Centers And Others, 2019-2027f (Usd Million)

  • 11.3. Global Cancer Screening Market Segmentation- By Region

§ North America Cancer Screening Market, 2019-2027f (Usd Million)

Ø Market Overview

Ø Market Size, 2019-2027f (Usd Million)

Ø Market Segmentation

  • By Diagnostic Method
  • By Type Of Cancer
  • By End User
  • By Country

§ Europe Cancer Screening Market, 2019-2027f (Usd Million)

Ø Market Overview

Ø Market Size, 2019-2027f (Usd Million)

Ø Market Segmentation

  • By Diagnostic Method
  • By Type Of Cancer
  • By End User
  • By Country

§ Asia Pacific Cancer Screening Market, 2019-2027f (Usd Million)

Ø Market Overview

Ø Market Size, 2019-2027f (Usd Million)

Ø Market Segmentation

  • By Diagnostic Method
  • By Type Of Cancer
  • By End User
  • By Country

§ Latin America Cancer Screening Market, 2019-2027f (Usd Million)

Ø Market Overview

Ø Market Size, 2019-2027f (Usd Million)

Ø Market Segmentation

  • By Diagnostic Method
  • By Type Of Cancer
  • By End User
  • By Country

§ Middle East & Africa Cancer Screening Market, 2019-2027f (Usd Million)

Ø Market Overview

Ø Market Size, 2019-2027f (Usd Million)

Ø Market Segmentation

  • By Diagnostic Method
  • By Type Of Cancer
  • By End User
  • By Country

12. Competitive Structure

  • 12.1. Detailed Overview
  • 12.2. Assessment Of Key Product Offerings
  • 12.3. Analysis Of Growth Strategies
  • 12.4. Key Collaborations And Joint Ventures
  • 12.5. Key Mergers And Acquisitions
  • 12.6. Recent News And Developments
  • 12.7. Key Clients And Partners
  • 12.8. Exhaustive Analysis On Key Financial Indicators
  • 12.9. Company Profiles Of Global Cancer Screening Market
    • 12.9.1. Roche
    • 12.9.2. Abbott
    • 12.9.3. Fujifilm
    • 12.9.4. Siemens Healthineers
    • 12.9.5. Ge Healthcare
    • 12.9.6. Thermo Fisher Scientific
    • 12.9.7. Olympus Corporation
    • 12.9.8. Agilent
    • 12.9.9. Other Market Players

13. Strategic Recommendations